Institutional Ownership
Sinovac Biotech Ltd
CUSIP P8696W104SHSSVAQ1 2026
13D / 13G Filings
32
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
32.3%
Max % of class reported
Institutional Holders
29
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
32 filings · latest Dec 17, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Dec 17, 2025 | Saif Partners IV L.P. | 13D/A | 15.0% | — | SEC |
| 2 | Sep 12, 2025 | 1globe Capital LLC | 13D/A | 32.3% | — | SEC |
| 3 | Jul 15, 2025 | Weidong Yin | 13D/A | 8.8% | — | SEC |
| 4 | Jul 14, 2025 | Advantech Capital L.P. | 13D/A | 8.1% | — | SEC |
| 5 | Jul 14, 2025 | Saif Partners IV L.P. | 13D/A | 15.0% | — | SEC |
| 6 | Jul 11, 2025 | Vivo Capital Viii, LLC | 13D/A | 6.3% | — | SEC |
| 7 | Jul 7, 2025 | 1globe Capital LLC | 13D/A | 32.3% | — | SEC |
| 8 | Jul 3, 2025 | 1globe Capital LLC | 13D/A | 32.3% | — | SEC |
| 9 | Jul 1, 2025 | 1globe Capital LLC | 13D/A | 32.3% | — | SEC |
| 10 | Jun 20, 2025 | Weidong Yin | 13D/A | 8.8% | — | SEC |
22 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Sinovac Biotech Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Orbimed Advisors LLC | 2.72M | $184.47M |
| 2 | Vivo Capital, LLC | 5.90M | $38.19M |
| 3 | Susquehanna International Group, LLP | 16.4K | $106.3K |
| 4 | Morgan Stanley | 9.1K | $59.2K |
| 5 | Wells Fargo & Company/Mn | 4.8K | $31.1K |
| 6 | Ubs Group AG | 2.2K | $14.4K |
| 7 | Neumann Advisory Hong Kong Ltd | 315.6K | $2.0K |
| 8 | Horizon Investments, LLC | 104 | $673 |
| 9 | Harbour Investments, Inc. | 83 | $542 |
| 10 | Jones Financial Companies Lllp | 338 | $0 |